A medical cable RFQ should define the cable’s role in the finished device before requesting a material or price. A cable inside an enclosure, a reusable operator-handled lead and a patient-contacting accessory have different risk and evidence boundaries. Calling all three “medical-grade” does not make their documentation or validation interchangeable.
This guide supports procurement and engineering planning. It does not provide clinical use instructions, a cleaning recipe or a declaration of device compliance. The finished-device manufacturer and its authorized specialists must determine intended use, applicable requirements and acceptance. TONFUL’s project proposal should be evaluated against that controlled scope, without assuming certifications or patient-contact suitability that have not been verified.
On this page: Intended use, Materials and cleaning, RFQ template, Validation, TONFUL enquiry.
Define Intended Use and Contact Boundaries
Describe the finished-device role
Identify the device, accessory, installation and market scope. Record whether the cable carries power, signals, patient-related measurements or communication. Define connector and circuit interfaces from controlled drawings. A plug that fits another device is not evidence of electrical or clinical compatibility, especially where apparently similar accessories have different assignments.
State whether the cable is internal, externally accessible, reusable or single-use. Include operator handling, movement, connection frequency and foreseeable service exposure. Identify the device risk owner and the documents that supply requirements. The cable supplier should not be asked to infer the intended medical application from a sample photograph.
Patient-contact claims need a precise boundary. Record whether contact is direct or indirect, the contacting surface, duration and use conditions as determined by the responsible device team. A cable hidden inside equipment may have no patient contact, while a jacket or molded grip on an accessory may be relevant. Do not declare all materials exempt or all materials subject to the same test program.
Separate biological evaluation from a material label
FDA’s ISO 10993-1 guidance discusses risk-based biological evaluation for devices with direct or indirect body contact. It does not establish that a generic polymer name or supplier declaration approves a finished medical cable. The applicable evaluation belongs to the device’s intended use and risk-management context.
Identify evidence for the finished contacting construction, including relevant manufacturing and processing effects. Colorants, adhesives, coatings, residues and reprocessing can matter alongside the base polymer. A report for one material coupon should not automatically be applied to a differently processed cable. Have the authorized specialist determine whether existing evidence is relevant and whether additional evaluation is needed.
Do not describe a cable as “FDA approved” based on a material statement. Likewise, a quality-management certificate such as ISO 13485 has a defined organization and scope; it is not finished-device approval or proof of biological suitability. Verify any requested supplier certificate and its relevance instead of assuming TONFUL holds it.
Specify Materials, Cleaning and Reprocessing
Make the material list traceable
Provide exact cable, conductor, insulation, jacket, connector, contact, seal and overmold requirements. Identify permitted sources and substitutions. Retain grade and formulation information where the project requires it, including color and additives. A replacement described as the same broad polymer family may still change cleaning compatibility or contact evidence.
Review the molded transition using the overmolded cable assembly guide. Define load path, surface interfaces and hidden inspection before encapsulation. A smooth boot may improve handling but cannot establish sealing, reprocessing resistance or absence of contamination without the relevant evaluation.
Define manufacturing cleanliness and handling controls from the application requirements. Do not invent a cleanroom class or sterile-manufacturing claim. Where residues or particles matter, specify the measurement method, sampling, limit source and responsibility. Distinguish production cleaning from the user’s later reprocessing method.
Cleaning, disinfection and sterilization are distinct
Record the approved process, agents, concentration, temperature, exposure time, drying and number of repetitions where applicable. These values must come from the device requirements and authorized validation plan. A cable compatible with routine wiping is not automatically compatible with immersion, a disinfectant or a sterilization process.
Assess the complete construction after the specified process. Review jacket change, cracking, adhesion, markings, connector condition and relevant electrical measurements. Surface appearance alone is not enough if the process affects hidden interfaces. If the assembly is not intended for reprocessing, define that boundary clearly in the product requirements.
Reusable applications need an agreed end-of-life and inspection strategy determined by the device owner. Do not translate a laboratory repetition count into unlimited use. Identify how damaged cables are recognized and removed from service in the approved instructions, without substituting this blog for those instructions.
Use a Copyable Technical and Commercial RFQ
Provide fields that suppliers can answer
| RFQ field | Required buyer entry or supplier response |
|---|---|
| Buyer and project | Company, device project and technical owner |
| Intended use | Internal, external, reusable or single-use scope |
| Contact boundary | Direct/indirect contact assessment and owner |
| Drawing | Assembly, circuit and connector revisions |
| Materials | Exact grades, colors, additives and approved sources |
| Dimensions | Length, branches, tolerances and mating envelope |
| Electrical duty | Supply, load, signals and protection |
| Handling | Flex, pull, connection frequency and support |
| Cleaning/reprocessing | Approved method and required compatibility evidence |
| Workmanship | Acceptance document, revision and deviations |
| Traceability | Component lots, assembly identity and record retention |
| Validation | Samples, conditions, tests and acceptance documents |
| Certificates | Requested organization/product scope and verification |
| Packaging | Protection, cleanliness, labels and storage conditions |
| Quantity | Sample quantity, annual demand and order breaks |
| Commercial terms | MOQ, currency, delivery location and quote validity |
| Tooling/NRE | Cost, ownership, maintenance and transfer conditions |
| Schedule | Sample and production timing with assumptions |
| Changes | Notification, approval and revalidation responsibilities |
| Response | Deviations, unresolved assumptions, signature and date |
Do not leave a missing requirement disguised as a supplier promise. If the buyer has not defined a cleaning process, the supplier should identify that gap rather than claim compatibility with all hospital agents. Mark unsupported evidence and propose the next review step. A quotation should separate confirmed scope from optional or pending work.
Compare proposals on the same boundary. Include tooling, validation, inspection, packaging and documentation where required. A lower unit price may exclude records or tests needed for release. Conversely, a long certification list is not useful if it does not cover the supplying site, activity or exact product.
Review manufacturing capability with evidence
Use the custom harness manufacturer audit guide to examine document control, training, tooling, inspection and traceability. Tailor the review to the medical project; do not assume a generic factory questionnaire covers the device owner’s supplier controls. Confirm outsourced processes and change-notification arrangements.
The manufacturing process guide connects assembly instructions with inspection records. Review concealed joints before overmolding or covering. Check how the supplier prevents mix-ups between externally similar variants, particularly when pin assignments differ. Labels and packaging should preserve the exact approved revision.
Plan Validation, Production Controls and Release
Define tests through the device requirements
Electrical testing should identify circuit coverage, measurement boundary, instrument capability and acceptance source. The continuity testing guide helps detect opens, shorts and miswires, but cannot establish complete medical-device electrical safety. Insulation, dielectric, leakage or other safety testing requires the applicable device-specific plan and qualified personnel.
Do not apply an arbitrary high test voltage to a cable containing electronics, suppression parts or attached equipment. Confirm test isolation and discharge requirements. Bench power requires verified contacts, supply range, polarity, protection and fixtures. Testing must not involve patients or substitute for authorized device verification.
Mechanical testing should define load direction, grips, speed, conditioning and failure criterion. Flex tests need representative routing and support. Cleaning or environmental exposure should follow the agreed sequence with baseline and aged measurements. Retain actual raw results rather than a general statement that the cable was “fully tested.”
Allocate samples and control approval status
Agree quantity and sample selection with the responsible project authority. Identify independent tests, sequential exposures, reference specimens and destructive-analysis allocation. Document invalid tests, failures and authorized retests. A replacement specimen must not erase the original result or conceal an unresolved material interface.
Separate fit review, sample approval and production approval. Fit approval can establish dimensions without completing biological, reprocessing or electrical evidence. Conditional purchase authorization needs a named scope, owner, expiry and closure conditions. The finished-device manufacturer retains responsibility for the system and its applicable regulatory release.
| Release record | Required evidence |
|---|---|
| Configuration | Cable part, revision, sample IDs and component lots |
| Requirement set | Device scope, approved documents and deviations |
| Evaluation | Relevant material/contact and processing evidence |
| Validation | Test plan, fixtures, conditioning and raw results |
| Production | Work instructions, inspection and traceability coverage |
| Packaging | Label, protection and storage verification |
| Decision | Approval level, limitations, reviewer and date |
Review production-intent evidence before serial purchase. A hand-built sample can establish feasibility but may not represent production tooling, cleaning or traceability. Require change review for materials, colorants, processes, subcontractors and test programs. An unchanged cable shape does not establish continued relevance of earlier evaluation results.
Receiving and complaint controls should preserve revision, lot and use context. Where a returned item has been exposed to a clinical environment, handling must follow the authorized safety process; do not ask ordinary personnel to open or clean it informally. Investigation should connect the failure evidence to the approved construction and applicable device requirements.
Work With TONFUL on a Controlled Medical Cable Enquiry
Send the intended-use definition, drawings, circuit duty, handling, cleaning requirements and requested documentation through TONFUL’s enquiry channel. Confirm the proposed manufacturing scope and evidence availability before making certification, biological-suitability or cleanroom claims.
A strong RFQ assigns responsibilities and makes unresolved assumptions visible. Approve the exact construction and application supported by the reviewed records, while keeping supplier assembly evidence, quality-system scope and finished-device compliance separate.